Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
The fifth Ovarian Cancer Consensus Conference (OCCC) of the Gynecologic Cancer InterGroup (GCIG) held in Tokyo in November 2015 gathered representatives from 29 collaborative research groups to propose international consensus statements on designing new clinical trials in ovarian cancer.
At the fifth Ovarian Cancer Consensus Conference (OCCC) of the Gynecologic Cancer InterGroup (GCIG) held in Tokyo, Japan, in November 2015, representatives of 29 international cooperative clinical trial groups in gynaecology oncology gathered to reach consensus on pre-defined questions considered critical to the conduct of randomised trials [1]. Group D, one of the four groups, focussed specifically on recurrent ovarian cancer (ROC).
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
